Preventing cardiac fibrosis appears to be the most prominent action of BNP, as evidenced by studies on mice with a targeted disruption of the BNP gene, displaying focal fibrotic lesions in the ventricles, without concurrent hypertension or ventricular hypertrophy [18]. The gene discussed is NPPB; the disease is Ventricular hypertrophy.